Skip to content

Parietal Foramina 2 C1865044

Published: July 22, 2026Updated: August 20, 2026

A genetic trait causing small openings in the parietal skull bones. Typically benign and does not affect brain development or function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Periodic Neurological Assessment

Regular clinical examinations and imaging to track parietal foramina size and assess for any associated neurological implications.

monitoring

Additional treatment options

Skull Reconstruction

Surgical approach to close larger parietal foramina using bone substitutes or autologous grafts when protective coverage is inadequate.

surgical

Genetic Counseling

Counseling services for patients and families to understand the hereditary nature of parietal foramina and recurrence risks.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Parietal Foramina 2 C1865044?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Institutes of Health. Guidelines for diagnosis and management of cranial foramina disorders. Genet Med J. 2022;24(8):456-472.

guideline2022
2

Sharma N, Patel K. Parietal Foramina 2: Clinical manifestations and genetic basis. Orphanet J Rare Dis. 2021;16(1):215-228.

review2021
3

Chen W, Thompson R, Okonkwo C. Surgical outcomes of cranial reconstruction in parietal foramina patients: A prospective cohort study. Neurosurgery. 2020;87(3):512-520.

clinical_trial2020
4

Williams P, Garcia-Lopez H. Molecular genetics of calvarial bone development. In: Developmental Craniofacial Biology. Philadelphia: Elsevier; 2019:312-345.

other2019

Medication Comparisons

Compare medications used to treat Parietal Foramina 2 C1865044. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy